ArticleScientific reports2023

First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment.

Mirna Burciaga-Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.